Profilo
Amy Edmonds worked as the Head of Clinical Operations at Celgene Corp.
from 2002 to 2012.
She also worked as the Secretary and VP of Clinical Operations & Administration at Bellerophon Therapeutics, Inc. Additionally, she received an undergraduate degree from the University of Richmond.
Precedenti posizioni note di Amy Edmonds
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/10/2012 |
| BELLEROPHON THERAPEUTICS, INC. | Direttore Amministrativo | - |
Formazione di Amy Edmonds
| University of Richmond | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Amy Edmonds
